Skip to content

Clinical trials

Phase 1/2 Esophageal Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1/2 Country / region: Belgium Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20181
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seagen Inc.2
Amgen1
Merus B.V.1
University Hospital, Antwerp1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms5
Ovarian Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Prostatic Neoplasms2
Stomach Neoplasms2
Urinary Bladder Neoplasms2
Uterine Cervical Neoplasms2
Biliary Tract Neoplasms1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.